How to reassess and discontinue psychiatric medications?
Psychiatric Deprescribing Guidance Signals a Turning Point in Mental Health Care
A new international consensus statement suggests clinicians should reassess psychiatric medications at least annually, verify adherence before declaring treatment failure, and involve patients in shared decision-making when considering deprescribing.
A 45-member international task force convened under the American Society of Clinical Psychopharmacology r…
